Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis

出版年份 2017 全文链接

标题

作者

关键词

Malignancies, Tofacitinib, JAK inhibitors, Biological disease-modifying antirheumatic drugs

出版物

SEMINARS IN ARTHRITIS AND RHEUMATISM

Volume 47, Issue 2, Pages 149-156

出版商

Elsevier BV

发表日期

2017-02-16

DOI

10.1016/j.semarthrit.2017.02.007

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started